venBio Global Strategic Fund II L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 12,204 shares at $27.03 ($330K) on 2020-02-06, disclosed to the SEC on 2020-02-10.
Open-market sale of $330k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.03 | 6,102 | $165K | 50.0% |
| 2 | $27.03 | 6,102 | $165K | 50.0% |
| Total | $27.03 avg | 12,204 | $330K | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |